经口CO(2)激光手术治疗累及前连合的声门型喉癌
回顾性分析32例前连合受累的声门型喉癌患者,均行经口CO(2)激光手术,其中T1bN0M0 27例、T2N0M0 5例。5年总生存率为90.6%,总5年局部区域控制率为84.4%;T1bN0M0与T2N0M0的5年局部区域控制率分别为92.6%和40.0%,差异有统计学意义。
要点
- 32例均顺利完成经口CO(2)激光手术,常见围手术期并发症为软腭或咽侧壁黏膜撕裂(13/32,40.63%)。
- 5年总生存率为90.6%;T1bN0M0与T2N0M0的5年生存率无显著差异(P=0.375)。
- T1bN0M0的5年局部区域控制率92.6%,显著高于T2N0M0的40.0%(P=0.002)。
核心结论
- 在严格掌握手术适应证、详细进行术前评估、恰当进行手术操作以及严格遵循肿瘤外科原则的前提下,经口CO(2)激光手术可达到满意疗效。
研究设计与样本
- 回顾性分析2009年3月至2013年12月接受经口CO(2)激光手术治疗的32例前连合受累的声门型喉癌患者的临床资料,其中T1bN0M0 27例、T2N0M0 5例。
主要发现
- 32例均顺利实施经口CO(2)激光手术;围手术期并发症包括软腭或咽侧壁黏膜撕裂13/32(40.63%)、门齿松动3/32(9.38%)和颈部皮下气肿2/32(6.25%)。
- 随访期内32例均出现创面肉芽组织增生;3例局部复发,其中2例再次接受激光手术、1例行喉全切除术,3例随访5年均无瘤生存。
- 2例出现颈部区域复发而无原发灶复发,其中1例行颈淋巴清扫术,随访5年无瘤生存,另1例术后40个月死于右锁骨上淋巴结、纵隔淋巴结转移及肺转移。
关键数值与推荐
- 5年总生存率90.6%;T1bN0M0为92.6%,T2N0M0为80.0%,二者差异无统计学意义(Log Rank χ(2)=0.788,P=0.375)。
- 总5年局部区域控制率84.4%;T1bN0M0为92.6%,显著高于T2N0M0的40.0%(Log Rank χ(2)=9.504,P=0.002)。
临床怎么用
- 对前连合受累的声门型喉癌,在严格掌握手术适应证、详细术前评估、恰当手术操作并遵循肿瘤外科原则的前提下,可考虑经口CO(2)激光手术。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the clinical outcome of transoral CO(2) laser surgery for glottic cancer involving the anterior commissure. Methods: Thirty-two cases of glottic cancer involving the anterior commissure treated by transoral CO(2) laser surgery between March 2009 and December 2013 were retrospectively reviewed. Among these cases, 27 were T1bM0M0, 5 were T2N0M0. All cases were followed-up for more than 3 years. Results: All the 32 cases were successfully treated. Perioperative complications included injuries in the soft palate mucosa(13/32, 40.63%), loose incisors(3/32, 9.38%) and subcutaneous emphysema in the neck(2/32, 6.25%). During the follow-up period, granulation was found in all cases. Three cases had local recurrence. Two patients treated by a secondary transoral CO(2) laser surgery and the other case had total laryngectomy, all three cases were followed up for 5 years without recurrence. Two cases had regional recurrence but no primary site recurrence. One patient was treated by neck dissection, and followed up for 5 years without recurrence. The other patient died of supraclavicular and mediastinal lymph node metastasis and lung metastasis 40 months after operation. The overall 5-year survival rate was 90.6%. There was no significant difference in survival rate between T1bN0M0(92.6%) and T2N0M0(80.0%) (Log Rank χ(2)=0.788, P=0.375). The overall 5-year local regional control rate was 84.4%. In T1bN0M0 lesions, the 5-year local regional control rate was 92.6%, which was significantly higher than that in T2N0M0 lesions(40.0%) (Log Rank χ(2)=9.504, P=0.002). Conclusion: With appropriate surgical indication, detailed preoperative evaluation, good surgical skill, transoral CO(2) laser surgery may achieve satisfactory outcome in the treatment of glottic cancer involving the anterior commissure. 目的: 探讨经口CO(2)激光手术切除前连合受累的声门型喉癌的可行性与临床疗效。 方法: 回顾性分析2009年3月至2013年12月接受经口CO(2)激光手术治疗的32例前连合受累的声门型喉癌患者临床资料,其中T1bN0M0 27例,T2N0M0 5例。 结果: 32例患者均顺利实施经口CO(2)激光手术,围手术期并发症发生率较高的为软腭或咽侧壁黏膜撕裂(13/32,40.63%)、门齿松动(3/32,9.38%)和颈部皮下气肿(2/32,6.25%)。随访期内,32例患者均出现创面肉芽组织增生,术后1~2个月为肉芽组织增生的高峰期,3个月后肉芽组织逐渐缩小,4~6个月时肉芽组织可完全消失,仅残留局部瘢痕或前连合粘连。3例出现局部复发,其中2例再次接受激光手术,1例行喉全切除术,3例随访5年均无瘤生存。2例出现颈部区域复发而无原发灶复发,其中1例行颈淋巴清扫术,随访5年无瘤生存,另1例术后40个月出现右锁骨上淋巴结、纵隔淋巴结转移及肺转移而死亡。Kaplan-Meier法计算本组患者5年总生存率90.6%,其中T1bN0M0病变者5年生存率92.6%,T2N0M0病变者5年生存率80.0%,二者差异无统计学意义(Log Rank检验,χ(2)=0.788,P=0.375);总5年局部区域控制率84.4%,其中T1bN0M0病变者5年局部区域控制率92.6%,T2N0M0病变者5年局部区域控制率40.0%,二者差异有统计学意义(Log Rank检验,χ(2)=9.504,P=0.002)。 结论: 对于前连合受累的声门型喉癌,在严格掌握手术适应证,详细进行术前评估,恰当进行手术操作以及严格遵循肿瘤外科原则的前提下,经口CO(2)激光手术可达到满意疗效。.
引用
- Li JJ, Zhang JL, He FY, et al. [Treatment of glottic cancer involving the anterior commissure by transoral CO(2) laser surgery]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28558451. doi:10.3760/cma.j.issn.1673-0860.2017.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。